LDL cholesterol targets rarely achieved in familial hypercholesterolemia patients: A sex and gender-specific analysis.

BACKGROUND AND AIMS: Despite lipid lowering therapy (LLT), reaching LDL-C targets in patients with familial hypercholesterolemia (FH) remains challenging. Our aim was to determine attainment of LDL-C target levels and reasons for not reaching these in female and male FH patients. METHODS: We performed a cross-sectional study of heterozygous FH patients in five hospitals in the Netherlands and Norway. Clinical characteristics and information about LLT, lipid levels and reasons for not being on LDL-C treatment target were retrospectively collected from electronic medical records. RESULTS: We studied 3178 FH patients (53.9% women), median age 48.0 (IQR 34.0-59.9) years. Median LDL-C before treatment and on-treatment was higher in women compared to men (6.2 (IQR 5.1-7.3) and 6.0 (IQR 4.9-7.2) mmol/l (p=0.005) and 3.0 (IQR 2.4-3.8) and 2.8 (IQR 2.3-3.5) mmol/L (p<0.001)), respectively. A minority of women (26.9%) and men (28.9%) reached LDL-C target. In patients with CVD, 17.2% of women and 25.8% of men reached LDL-C target. Women received less often high-intensity statins and ezetimibe. Most common reported reasons for not achieving the LDL-C target were insufficient effect of maximum LLT (women 17.3%, men 24.3%) and side effects (women 15.2%, men 8.6%). CONCLUSIONS: In routine practice, only a minority of women and men with FH achieved their LDL-C treatment target. Extra efforts have to be made to provide FH patients with reliable information on the safety of statins and their long-term effects on CVD risk reduction. If statin treatment is insufficient, alternative lipid lowering therapies such as ezetimibe or PCSK9-inhibitors should be considered.

[Non-union of the maxilla: a rare complication after Le Fort I osteotomy]. / Pseudarthrose du maxillaire après ostéotomie de Le Fort I.

INTRODUCTION: Maxillary non-union following Le Fort I osteotomy is a rare complication in orthognathic surgery. We report our experience and analyze the possible etiological factors. PATIENTS AND METHOD: We retrospectively analyzed the files of 150 patients having undergone Le Fort I osteotomy, between 1996 and 2006, screening for maxillary non-union. We documented patients' features of: sex, age, medical history, indication, orthodontics, osteotomy type(s) and displacement(s), osteosynthesis, quality of dental occlusion, orthodontics, clinical signs supporting a diagnosis of non-union, radiologic examinations, peroperative observations and surgical revision, outcome after surgical revision. RESULTS: Maxillary non-union was observed in four patients (2.6%). They were female patients with a mean age of 34 years (30 to 38 years) without any specific medical history. All underwent bimaxillary osteotomy (including one Le Fort I segmented osteotomy) for a class III (retromaxillary and promaxillary) associated to vertical disharmony (open-bite and/or transverse discrepancy). Maxillary displacements were always associated to advancement (average: 6mm, 4 to 8mm) and a vertical displacement (upward in three cases, downward in one case). In every case the maxilla was osteosynthesized with titanium miniplates, with four holes and 1.5 screws. Postoperative dental occlusion was deficient in every case, requiring surgical revision of orthodontics between four to six weeks after osteotomy. Clinical signs suggesting non-union were in every case maxillary mobility associated in three cases to discomfort. The mean delay between osteotomy and the non-union was 15.5 months (six to 56 months). These signs appeared after infection in three cases (maxillary sinusitis in two cases, dacryocystitis in one case). Conventional radiological (panoramic and lateral cephalometric radiographs) suggested non-union (plate fracture) in two cases and 3D computed tomography was required in every case to make a diagnosis. Surgical revision was decided for all patients (osteotomy site curettage, bone graft and a more stable osteosynthesis using 2.0 screws). Bone healing was achieved in every case after revision surgery. DISCUSSION: The incidence of non-union in our series was superior to that of published data (0.33 to 0.8%). Non-union always appeared in instable occlusion settings, and in three cases because of postoperative infection, but the main risk factor seemed to be osteosynthesis instability. Maxillary mobility is the key sign to screen for. Osteosynthesis material rupture or loosening is present every time but not always visible on standard radiography. 3D CT scan always allows observing non-union. Revision surgery combines curettage, bone graft, and a stronger osteosynthesis.

Fifteen years experience with finger arterial pressure monitoring: assessment of the technology.

We review the Finapres technology, embodied in several TNO-prototypes and in the Ohmeda 2300 and 2300e Finapres NIBP. Finapres is an acronym for FINger Arterial PRESsure, the device delivers a continuous finger arterial pressure waveform. Many papers report on the accuracy of the device in comparison with intra-arterial or with noninvasive but intermittent blood pressure measurements. We compiled the results of 43 such papers and found systolic, diastolic and mean accuracies, in this order, ranging from -48 to 30 mmHg, from -20 to 18 mmHg, and from -13 to 25 mmHg. Weighted for the number of subjects included pooled accuracies were -0.8 (SD 11.9), -1.6 (8.3) and -1.6 (7.6) mmHg respectively. Subdividing the pooled group according to criteria such as reference blood pressure, place of application, and prototype or commercial device we found no significant differences in mean differences or SD. Measurement at the finger allows uninterrupted recordings of long duration. The transmission of the pressure pulse along the arm arteries, however, causes distortion of the pulse waveform and depression of the mean blood pressure level. These effects can be reduced by appropriate filtering, and upper arm 'return-to-flow' calibration to bring accuracy and precision within AAMI limits. For the assessment of beat-to-beat changes in blood pressure and assessment of blood pressure variability Finapres proved a reliable alternative for invasive measurements when mean and diastolic pressures are concerned. Differences in systolic pressure are larger and reach statistical significance but are not of clinical relevance. Finger arteries are affected by contraction and dilatation in relation to psychological and physical (heat, cold, blood loss, orthostasis) stress. Effects of these phenomena are reduced by the built-in Physiocal algorithm. However, full smooth muscle contraction should be avoided in the awake patient by comforting the patient, and covering the hand. Arterial state can be monitored by observing the behaviour of the Physiocal algorithm. We conclude that Finapres accuracy and precision usually suffice for reliable tracking of changes in blood pressure. Diagnostic accuracy may be achieved with future application of corrective measures.

Non-invasive continuous finger blood pressure measurement during orthostatic stress compared to intra-arterial pressure.

STUDY OBJECTIVE: The aim of the study was to evaluate whether invasive blood pressure responses to orthostatic stress can be replaced by non-invasive continuous finger blood pressure responses. DESIGN - Intrabrachial and Finapres blood pressures were simultaneously measured during passive head up tilt and during active standing from the supine or sitting position in healthy volunteers. SUBJECTS: Subjects (n = 11) were healthy males aged 22-40 years, mean age 30 years. MEASUREMENTS AND MAIN RESULTS: Beat to beat values of systolic, diastolic, and mean arterial pressures were calculated for both methods of measurement and the differences compared during a 30 s control period before, and during the first 120 s after, the change of posture. In the control period the difference between finger pressure and intra-arterial pressure was +2 (SD11) mm Hg for systolic, -4(8) mm Hg for mean, and -3(7) mm Hg for diastolic pressure. Compared to these control differences, the average finger minus intra-arterial pressure differences for mean and diastolic pressures during the three orthostatic manoeuvres were always within the range -6 to +6 mm Hg. The average systolic deviations were larger, ranging from -10 to +11 mm Hg. Despite these differences the characteristic changes in intra-arterial pressure during the initial phase (first 30 s after change of posture), as well as during the early steady state phase (1-2 min after the change of posture) were well reflected by finger pressure measurements in all subjects. CONCLUSIONS: For the assessment of the continuous blood pressure responses to orthostatic stress similar information can be obtained with non-invasive Finapres blood pressure recordings as with invasive recordings.

Continuous non-invasive blood pressure monitoring: reliability of Finapres device during the Valsalva manoeuvre.

Because of the inherent risks of intra-arterial blood pressure monitoring a new non-invasive device, Finapres, which measures blood pressure continuously in the finger, was evaluated in 14 hypertensive and one normotensive subject. Brachial intra-arterial and finger pressures were compared during a control period and a subsequent Valsalva manoeuvre. Visually, blood pressures measured by Finapres faithfully reproduced the intra-arterial recordings in all subjects. From each pressure signal beat to beat systolic, diastolic, and mean blood pressure values and their differences were obtained and the time course of the response and its characteristic features were analysed. During the control period the Finapres measurements were lower than intra-arterial systolic, mean, and diastolic pressures (mean(SD) 1(9.6), 9(6.8), and 4(6.1) mmHg respectively). During the response to the Valsalva manoeuvre the brachial-finger pressure differences showed limited deviation from those during the control period; median differences were at most 6 mmHg occurring late during the intrathoracic strain period and 7 mmHg during the post-release blood pressure overshoot. In general, the Finapres device reproduced intra-arterial patterns faithfully. This device appears to offer a reliable alternative to intra-arterial blood pressure monitoring.

[Toothache: At what point has a pontocerebellar angle tumor to be evoked?]. / Odontalgie : quand évoquer une tumeur de l'angle ponto-cérébelleux?

INTRODUCTION: Dental pain may have another origin than teeth. It may be caused by myofascial, neurovascular, cardiac, neurological, sinusal or psychological factors. We will discuss 2 rare cases of patients who presented with a cerebellopontine tumor, who initially manifested with symptoms of dental pain. OBSERVATION: The first patient, male, 44 years of age presented to his dentist with toothache (47), which led to its extraction. Five months later, a second painful episode, more characteristic, revealed the presence of a vestibular schwannoma, which was successfully treated and led to the disappearance of the pain. The second case, a 43-year-old female presented to her dentist with toothache (46), which lead the dentist perform a root filling. Two years later, with a 3rd episode of dental pain, more relevant of a trigeminal neuralgia, a epidermoid cyst of the right cerebellopontine angle was identified and successfully treated leading to the disappearance of the pain. DISCUSSION: Cerebellopontine tumors of this type may lead, in exceptional cases to symptoms of dental pain. Therefore, in face of atypical tooth or facial pain, both a detailed medical history and a detailed examination are necessary, in order to investigate any neurological signs and symptoms, before undertaking any non-essential dental treatment, which may be detrimental for the patients.

Circadian profile of systemic hemodynamics.

We determined the continuous 24-hour profile of mean arterial pressure, heart rate, stroke volume, cardiac output, and total peripheral resistance in eight healthy ambulatory volunteers. Beat-to-beat intra-arterial blood pressure was recorded with the Oxford system; subjects were ambulant during daytime and slept at night. Beat-to-beat stroke volume was determined by the pulse contour method from the arterial pulse wave. During the nighttime, compared with the daytime average, there was a decrease in blood pressure (9 mm Hg), heart rate (18 beats per minute), and cardiac output (29%); stroke volume showed a small decrease (7%), and total peripheral resistance increased unexpectedly by 22%. When subjects arose in the morning a steep increase in cardiac output and decrease in total peripheral resistance were found. Comparable changes were seen during a period of supine resting in the afternoon, whereas physical exercise caused opposite changes in hemodynamics. This pattern was observed in all subjects. We conclude that the circadian pattern of cardiac output and total peripheral resistance originates from the day-night pattern in physical activity: during the nighttime, blood flow to the skeletal muscles is decreased through local autoregulation, which increases total peripheral resistance and decreases cardiac output compared with the daytime.

Effects of aging on blood pressure variability in resting conditions.

The objective of this study was to determine the effect of aging on beat-to-beat blood pressure and pulse interval variability in resting conditions and to determine the effect of aging on the sympathetic and vagal influence on the cardiovascular system by power spectral analysis of blood pressure and pulse interval. We studied three groups of healthy, normotensive subjects: young (10 to 15 years, n = 16), adult (20 to 40 years, n = 16), and elderly (70 to 90 years, n = 25). Beat-to-beat blood pressure was measured by Finapres during 20 minutes supine and 10 minutes standing. Overall systolic and diastolic blood pressures and pulse interval variability were determined as SD and as coefficient of variation. Also, relative powers of the mid-frequency (0.08 to 0.12 Hz) and high-frequency bands (0.15 to 0.40 Hz) were determined by spectral analysis. In these subjects no differences in blood pressure variability (either as SD or coefficient of variation) were found between age groups, except for the coefficient of variation of standing diastolic blood pressure, which decreased with aging. Pulse interval variability decreased with aging. Power of the mid-frequency band of systolic and diastolic blood pressures was markedly decreased in the elderly, especially in the standing position. Power of the high-frequency band of pulse interval was also decreased in the elderly. Baroreflex sensitivity calculated by fast Fourier transformation spectral analysis was decreased in the elderly subjects compared with the younger groups. In conclusion, we found no change in the overall variability of blood pressure with aging. Mid-frequency spectral power of blood pressure and mid- and high-frequency spectral powers of pulse interval variability were decreased in the elderly. These results suggest that aging does not merely influence the magnitude of blood pressure and pulse interval variability but causes a complex rearrangement of the variability pattern by changes in neurocardiovascular regulation.

Estimation of blood pressure variability from 24-hour ambulatory finger blood pressure.

Portapres is a noninvasive, beat-to-beat finger blood pressure (BP) monitor that has been shown to accurately estimate 24-hour intra-arterial BP at normal and high BPs. However, no information is available on the ability of this device to accurately track ambulatory BP variability. In 20 ambulatory normotensive and hypertensive subjects, we measured 24-hour BP by Portapres and through a brachial artery catheter. BP and pulse interval variabilities were quantified by (1) the SDs of the mean values (overall variability) and (2) spectral power, computed either by fast Fourier transform and autoregressive modeling of segments of 120-second duration for spectral components from 0.025 to 0.50 Hz or in a very low frequency range (between 0.00003 and 0.01 Hz) by broadband spectral analysis. The 24-hour SD of systolic BP obtained from Portapres (24+/-2 mm Hg) was greater than that obtained intra-arterially (17+/-1 mm Hg, P<0.01), but the overestimation was less evident for diastolic (3+/-1 mm Hg, P<0.01) and mean (3+/-1 mm Hg, P<0.01) BP. The BP spectral power <0.15 Hz was also overestimated by Portapres more for systolic than for diastolic and mean BPs; similar findings were obtained by the fast Fourier transform, the autoregressive approach, and focusing on the broadband spectral analysis. BP spectral power >0.15 Hz obtained by the Portapres was similar during the day but lower during the night when compared with those obtained by intra-arterial recordings (P<0.01). No differences were observed between Portapres and intra-arterial recordings for any estimation of pulse interval variabilities. The overestimation of BP variability by Portapres remained constant over virtually the entire 24-hour recording period. Thus, although clinical studies are still needed to demonstrate the clinical relevance of finger BP variability, our study shows that Portapres can be used with little error to estimate 24-hour BP variabilities if diastolic and mean BPs are used. For systolic BP, the greater error can be minimized by using correction factors.

Feasibility of ambulatory, continuous 24-hour finger arterial pressure recording.

We tested Portapres, an innovative portable, battery-operated device for the continuous, noninvasive, 24-hour ambulatory measurement of blood pressure in the finger. Portapres is based on Finapres, a stationary device for the measurement of finger arterial pressure. Systems were added to record signals on tape, to alternate measurements between fingers automatically each 30 minutes, and to correct for the hydrostatic height of the hand. We compared the pressure as measured by Portapres with contralateral intrabrachial pressure measured with an Oxford device. Results were obtained in eight volunteers and 16 hypertensive patients. Time lost due to artifact was about 10% for each device. In two patients a full 24-hour Oxford profile was not obtained. In the remaining 22 subjects finger systolic, diastolic, and mean pressures differed +1 (SD 9), -8 (6), and -10 (6) mm Hg, respectively, from intrabrachial pressure. These diastolic and mean pressure underestimations are similar to what was found earlier for Finapres, are typical for the technique, and are systematic. Avoiding brisk hand movements resulted in fewer waveform artifacts. The hand had to be kept covered to continue recording at low outside temperatures. Sleep was not disturbed by Portapres, and arterial pressure showed a marked fall during siesta and nighttime. There were no major limitations in behavior, and no discomfort that originated from continuous monitoring was reported. Measurements continued normally during physical exercise. Portapres provides for the first time continuous 24-hour, noninvasive ambulatory blood pressure waveform monitoring and offers real and obvious advantages over current noninvasive and invasive devices.

Effects of graded vasoconstriction upon the measurement of finger arterial pressure.

OBJECTIVE: To assess the effects of incremental phenylephrine infusion rates and subsequent graded vasoconstriction upon the performance of the Ohmeda Finapres. DESIGN: Blood pressure in eight hypertensive patients in the finger and the brachial artery was recorded simultaneously. Systolic blood pressure (SBP), diastolic blood pressure (DPB) and mean arterial pressure (MAP) were compared as well as additional waveform characteristics like the pressure at moment of the dicrotic notch and calculation of the pulsatile-systolic areas. RESULTS: Before phenylephrine infusion SBP and DBP were higher in the finger. At maximal infusion (1.6 micrograms/kg/min) the increase in brachial SBP was significantly underestimated by Finapres. Thus, the computed sensitivities of baroreflex control for SBP differed significantly between the two measurements. Under control conditions, the shape of the finger waveform differed from the brachial-artery waveform in terms of: (1) a more peaked appearance; (2) a dicrotic notch (Pnotch) which is located at a lower percentage of pulse pressure; and (3) a larger pulsatile-systolic area. At maximal infusion rates finger Pnotch increased whilst intrabrachial Pnotch did not. In contrast, the brachial and finger pulsatile-systolic areas changed fully in parallel. CONCLUSIONS: Phenylephrine infusion caused a significant, and clinically important, underestimation of the increase in brachial SBP when assessed by Finapres, whereas MAP and DBP and pulsatile-systolic area track intra-arterial pressure reliably.

Reproducibility of non-invasive and intra-arterial blood pressure monitoring: implications for studies on antihypertensive treatment.

Ambulatory blood pressure has been shown to be more reproducible than office blood pressure and thus to be more suited for studying the efficacy of antihypertensive drugs. In 34 untreated essential hypertensive subjects, we measured office and 24-h non-invasive or intra-arterial blood pressure twice over a 4-week interval; 24-h intra-arterial blood pressure was obtained by the Oxford method whereas 24-h non-invasive blood pressure was obtained by the automatic SpaceLabs 5300 device, with a 10 min (daytime) or 20 min (night-time) interval between measurements. The standard deviation of the mean difference (s.d.d.) between blood pressures obtained in each recording was taken as the reciprocal of blood pressure reproducibility. The s.d.d. was highest for office blood pressure and for single blood pressure readings taken from 24-h non-invasive recordings. The s.d.d. fell when the two 24-h average non-invasive blood pressures were considered. The fall was progressively greater as the number of ambulatory readings on which the average was calculated increased from two to 24, no further fall being observed when more than 24 values were considered. The maximal reduction in s.d.d. was 59% (systolic) and 42% (diastolic) as compared with the office s.d.d. The two 24-h mean values obtained by the intra-arterial approach were slightly more closely correlated than those obtained non-invasively. However, at comparable sampling rates, the s.d.d. was not substantially lower with 24-h intra-arterial blood pressure and including in the calculation the average of the thousand readings provided by this approach did not cause any further improvement.(ABSTRACT TRUNCATED AT 250 WORDS)

Finapres tracking of systolic pressure and baroreflex sensitivity improved by waveform filtering.

OBJECTIVE: Arterial pressure waveforms distort between brachial and finger arteries, causing differences mainly in systolic pressure. Distortion, reportedly, can be removed by applying a waveform filter to the finger pressure. DESIGN: We analysed the data from two studies that detected discrepancies in systolic tracking between Finapres and brachial pressures. The first set comprised waveforms of seven volunteers during incremental bicycle exercise to exhaustion and the second set comprised waveforms of eight volunteers during increasing phenylephrine infusion. METHODS: We applied the filter and compared 1 min averaged unfiltered and waveform-filtered finger and brachial pressures. RESULTS: During exercise, finger systolic pressure overestimated brachial increasingly, from 7(SD 10) mmHg at rest to 27(17) mmHg at maximal exertion. Differences were reduced by waveform filtering from 3 (SD 9)mmHg at rest to 1 (SD 15)mmHg at maximal exertion. During phenylephrine infusion finger systolic pressure overestimated brachial pressure, but the magnitude of the overestimate decreased from 14 (SD 15)mmHg at baseline to -1(SD 16)mmHg at maximal rate. After waveform filtering overestimation was an almost constant 6(SD 11)mmHg. Median baroreflex sensitivities from brachial, unfiltered and waveform-filtered finger pressure were 5.8, 7.5 and 5.3 ms/mmHg and correlation increased after filtering. The results indicate improved systolic pressure tracking after waveform filtering. CONCLUSIONS: Finger pressure distortion follows a general pattern correctable by waveform filtering. Waveform filtering allows a 'brachial' view to be obtained from Finapres data.

The reliability of noninvasive continuous finger blood pressure measurement in patients with both hypertension and vascular disease.

In conditions of compromised peripheral circulation, the measurement of noninvasive continuous finger blood pressure with the Finapres device may show reduced accuracy. We therefore compared Finapres blood pressure (FINAP) with intrabrachial blood pressure (IAP) responses to the Valsalva maneuver and arising in 12 patients in whom the peripheral circulation was expected to be compromised due to the combination of therapy-resistant hypertension and vascular disease. During a 30 sec control period the FINAP--IAP differences were -15.7 +/- 18.8 mm Hg (mean +/- SD) for systolic, -20.1 +/- 15.7 mm Hg for mean, and -13.5 +/- 15.7 mm Hg for diastolic pressure. During the Valsalva maneuver and prolonged standing Finapres reproduced the essential characteristics of the changes in IAP in all patients. However, in individual patients, the magnitude of the intraarterial blood pressure response was sometimes over- or underestimated by Finapres. Nevertheless, the group averaged blood pressure, in particular mean and diastolic pressure, response to cardiovascular stimuli, was well reproduced by Finapres. In conclusion, as expected physiologically, individual Finapres measurements in patients with vascular disease do not always equal the intrabrachial pressure and should thus be evaluated with care. However, the Finapres device can be used with sufficient confidence to study the group averaged responses to cardiovascular stimuli in these patients.

Initial blood pressure fall on stand up and exercise explained by changes in total peripheral resistance.

To elucidate the underlying mechanisms of the initial fall in blood pressure on standing upright from the supine position, we measured the beat-to-beat changes in intra-arterial pressure in eight healthy male subjects in response to standing. Changes in stroke volume, cardiac output, and total peripheral resistance were computed from the pressure waveform using a pulse contour method. To determine possible mechanisms for the changes observed on standing, similar measures were made on passive tilting and a brief (3-s) bout of cycle exercise. Standing elicited a transient 25% (23-mmHg) fall in mean blood pressure as a result of a 36% fall in total peripheral resistance. Head-up tilt elicited a gradual change in haemodynamic parameters, which reached plateau levels in 20-30 s. Cycling elicited a transient 17% (18-mmHg) fall in blood pressure and a 41% fall in total peripheral resistance. In addition, we measured right atrial and esophageal pressures in two subjects on standing and cycling and found a 10- to 15-mmHg rise in right atrial pressure without a corresponding change in esophageal pressure. This points to the cardiopulmonary reflex as the primary effector of peripheral vasodilation, but we cannot exclude the possibility that 1) local metabolic vasodilation and 2) central command-mediated cholinergic vasodilation contributed to the fall in vascular resistance.

Singing-induced hypotension: a complication of a high spinal cord lesion.

Cardiovascular autonomic control was studied in a patient with an incomplete high spinal cord lesion who presented with the symptoms of severe dizziness during debating and singing but not during orthostasis. The marked falls in blood pressure upon singing and orthostasis (45 degrees passive head-up tilt) were comparable in magnitude but different in time course. The fall in blood pressure upon graded Valsalva manoeuvres, however, was comparable to singing in magnitude and time course; similarly, 20 and 30 mmHg strain evoked complaints of dizziness. These differential circulatory responses upon orthostasis versus singing and Valsalva in tetraplegic patients have not been described before. We suggest that rapidly developing hypotension such as that induced by a moderate Valsalva strain represents the instantaneous mechanical effects of a raised intrathoracic pressure with lack of abdominal compression on the cardiovascular system when baroreflex vasomotor modulation is disrupted.

[Pressor effect of a soccer match (1988 European championship), registered via the Portapress]. / Pressor-effect van een voetbalwedstrijd (Europees Kampioenschap 1988), geregistreerd met de Portapres.

With the Portapres, continuous ambulatory non-invasive measurement of finger arterial blood pressure is possible. By means of this system blood pressure measurements were made in five healthy male subjects watching a match of the Dutch National team at home, during the 1988 European Championship. In two of them an evident pressor response was found.

Comparison of Finapres non-invasive beat-to-beat finger blood pressure with intrabrachial artery pressure during and after bicycle ergometry.

To evaluate the accuracy of continuous non-invasive blood pressure measurements in the finger during exercise, Finapres blood pressures of six normotensive healthy males were measured during increasing levels of bicycle exercise, using simultaneously registered ipsilateral intrabrachial artery pressures as a reference. At rest, finger systolic blood pressure was higher and finger diastolic and mean arterial pressures were lower than the corresponding intrabrachial pressures in five of the six subjects. During exercise, average finger diastolic and mean arterial pressures did not differ further from these intrabrachial pressures, but finger systolic pressure increased considerably more than the direct systolic pressure, exceeding it by 26 +/- 20 mmHg (mean +/- s.d.) at maximal exercise. This latter finding potentially limits the use of finger blood pressure measurements during exercise.

Septic thrombosis of the cavernous sinus secondary to a Streptococcus milleri oral infection.

Septic thrombosis of the cavernous sinus (STCS) is an uncommon and potentially lethal disease. Sphenoid and ethmoid sinusitis followed by facial cutaneous infections represents the most common aetiologies, with Staphylococcus aureus as the main responsible organism followed by the Streptococcus pneumoniae. Although all infectious foci of the head and neck area can potentially spread to the cavernous sinus, STCS from oral infection is an exceptionally rare occurrence. We report the unusual case of a patient who presented with an acute STCS secondary to a generalized Streptococcus milleri periodontitis. This case highlights the importance of systematically performing a detailed examination of the oral cavity in patients presenting with intracranial infections caused by uncommon pathogens such as the Streptococcus milleri group.

Evaluation of cholesterol lowering treatment of patients with familial hypercholesterolemia: a large cross-sectional study in The Netherlands.

BACKGROUND: Heterozygous familial hypercholesterolemia (heFH) is a common autosomal dominant hereditary disorder caused by mutations in the LDL-receptor gene that lead to elevated plasma levels of low-density lipoprotein-cholesterol (LDL-c). Robust lowering of LDL-c levels is essential for risk reduction of premature cardiovascular diseases and early death. European and Dutch guidelines recommend to treat LDL-c to plasma levels <2.5mmol/l. In the present study we evaluated the treatment of heFH patients in The Netherlands. METHODS: A cross-sectional study was conducted in outpatient lipid clinics of three Academic Centers and two regional hospitals. Patient records of known heFH patients were retrieved and data were reviewed on the use of lipid-lowering medication, plasma lipids and lipoproteins, safety laboratory results and reasons for not achieving treatment goals. RESULTS: The data of 1249 patients with heFH were available. Nearly all patients (96%) were on statin treatment. The treatment goal for LDL-c <2.5mmol/l was achieved in 261 (21%) patients. Among those who did not reach LDL-c goals, 261 (27%) were on combination therapy of maximum statin dose and ezetimibe. Main reason (32%) why patients did not use maximum therapy despite an LDL-c >or=2.5mmol/l, was acceptance of a higher target LDL-c level by the treating physician. An alternative treatment goal of >50% LDL-c reduction, as recommended in the NICE guidelines, was achieved in 47% of patients with an LDL-c >or=2.5mmol/l and not using maximum therapy. CONCLUSION: Only a small proportion of patients with heFH reaches the LDL-c treatment target of <2.5mmol/l. These results emphasize the need for better monitoring, better utilization of available medication and for new treatment options in heFH to further decrease LDL-c levels.